Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1970 1
1971 5
1972 5
1973 4
1974 4
1975 5
1976 5
1977 6
1978 3
1979 6
1980 6
1981 3
1982 12
1983 16
1984 5
1985 12
1986 8
1987 11
1988 9
1989 16
1990 17
1991 13
1992 19
1993 17
1994 10
1995 22
1996 19
1997 15
1998 14
1999 19
2000 26
2001 20
2002 17
2003 20
2004 22
2005 21
2006 20
2007 13
2008 19
2009 9
2010 5
2011 3
2012 15
2013 11
2014 7
2015 8
2016 8
2017 8
2018 6
2019 6
2020 11
2021 4
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

581 results
Results by year
Filters applied: . Clear all
Page 1
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: lode hn. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
The impersonator.
Lode H, Wagner J, Scherübl H. Lode H, et al. Am J Med. 2007 Mar;120(3):239-41. doi: 10.1016/j.amjmed.2007.01.019. Am J Med. 2007. PMID: 17349446 No abstract available.
[Diagnosis of haemoptoe/haemoptysis].
Allewelt M, Lode H. Allewelt M, et al. Among authors: lode h. Dtsch Med Wochenschr. 2005 Mar 4;130(9):450-2. doi: 10.1055/s-2005-863074. Dtsch Med Wochenschr. 2005. PMID: 15731957 Review. German.
Impact of Bacterial Toxins in the Lungs.
Lucas R, Hadizamani Y, Gonzales J, Gorshkov B, Bodmer T, Berthiaume Y, Moehrlen U, Lode H, Huwer H, Hudel M, Mraheil MA, Toque HAF, Chakraborty T, Hamacher J. Lucas R, et al. Among authors: lode h. Toxins (Basel). 2020 Apr 2;12(4):223. doi: 10.3390/toxins12040223. Toxins (Basel). 2020. PMID: 32252376 Free PMC article. Review.
[Therapy of sarcoidosis].
Schaberg T, Schönfeld N, Loddenkemper R, Lode H. Schaberg T, et al. Among authors: lode h. Dtsch Med Wochenschr. 1995 May 19;120(20):725-7. doi: 10.1055/s-2007-1024056. Dtsch Med Wochenschr. 1995. PMID: 7758412 Review. German. No abstract available.
[Therapy of tuberculosis].
Schaberg T, Lode H. Schaberg T, et al. Among authors: lode h. Dtsch Med Wochenschr. 1990 Nov 23;115(47):1799-802. doi: 10.1055/s-2008-1065229. Dtsch Med Wochenschr. 1990. PMID: 2226195 Review. German. No abstract available.
Toxicity of quinolones.
Stahlmann R, Lode H. Stahlmann R, et al. Among authors: lode h. Drugs. 1999;58 Suppl 2:37-42. doi: 10.2165/00003495-199958002-00007. Drugs. 1999. PMID: 10553703 Review.
Pharmacodynamics of fluoroquinolones.
Lode H, Borner K, Koeppe P. Lode H, et al. Clin Infect Dis. 1998 Jul;27(1):33-9. doi: 10.1086/514623. Clin Infect Dis. 1998. PMID: 9675446 Review.
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
Seitz CM, Flaadt T, Mezger M, Lang AM, Michaelis S, Katz M, Syring D, Joechner A, Rabsteyn A, Siebert N, Troschke-Meurer S, Zumpe M, Lode HN, Yang SF, Atar D, Mast AS, Scheuermann S, Heubach F, Handgretinger R, Lang P, Schlegel P. Seitz CM, et al. Among authors: lode hn. Front Immunol. 2021 Jul 22;12:690467. doi: 10.3389/fimmu.2021.690467. eCollection 2021. Front Immunol. 2021. PMID: 34367149 Free PMC article. Clinical Trial.
Gemifloxacin for community-acquired pneumonia.
Lode HM, Schmidt-Ionas M, Stahlmann R. Lode HM, et al. Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779. Expert Opin Investig Drugs. 2008. PMID: 18447602 Review.
581 results